Related Experiment Video

Updated: May 10, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
07:23

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome

Published on: June 15, 2016

Downregulation of Stat3 in melanoma: reprogramming the immune microenvironment as an anticancer therapeutic strategy

P U Emeagi1, S Maenhout, N Dang

  • 1Laboratory of Molecular and Cellular Therapy, Department of Immunology-Physiology, Vrije Universiteit Brussel, Jette, Belgium.

Gene Therapy
|June 28, 2013
PubMed

Insights

This study shows that targeting Signal Transducer and Activator of Transcription 3 (Stat3) with lentiviral short hairpin RNA (LV-shStat3) in melanoma reduces tumor growth. Stat3 downregulation boosts antitumor immunity by increasing immune cell activity and reducing suppressive cells.

Area of Science:

  • Oncology
  • Immunology
  • Gene Therapy

Background:

  • Persistent activation of Signal Transducer and Activator of Transcription 3 (Stat3) drives oncogenesis in various cancers, including melanoma.
  • Stat3 plays a critical role in mediating tumor growth and immune evasion.

Purpose of the Study:

  • To investigate the effect of lentiviral (LV) delivery of Stat3-targeting short hairpin RNA (shRNA; LV-shStat3) on melanoma antitumor immunity.
  • To assess the therapeutic potential of Stat3 downregulation in melanoma treatment.

Main Methods:

  • K1735-C4 melanoma cells were transduced with LV-shStat3 targeting different Stat3 sequences.
  • In vitro and in vivo experiments were conducted to evaluate Stat3 downregulation, cell viability, gene expression, and immune cell modulation.
  • Tumor growth and survival rates in tumor-bearing mice were monitored after LV-shStat3 injection.

Main Results:

  • LV-shStat3 successfully downregulated Stat3 in melanoma cells, leading to reduced cell viability, survivin, and MMP-2 expression in vitro.
  • In vivo, LV-shStat3 decreased vascular endothelial growth factor secretion and myeloid-derived suppressor cell (MDSC) numbers.
  • An increase in interleukin-6, interferon-γ, mature dendritic cells (DCs), and CD8(+) T cells was observed, with enhanced immune cell activity and reduced MDSC suppressive capacity.
  • A single LV-shStat3 injection significantly reduced tumor growth and prolonged survival in mice.

Conclusions:

  • Stat3 downregulation via LV-shStat3 effectively inhibits melanoma growth and progression.
  • Targeting Stat3 reinvigorates the host's antitumor immune response by modulating immune cell populations and function.
  • LV-shStat3 represents a promising therapeutic strategy for melanoma by enhancing anti-tumor immunity.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...